Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew P R Sutherland

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Pharmacology & Therapeutics|July 26, 2006
Targeting BAFF: immunomodulation for autoimmune diseases and lymphomasAndrew P R Sutherland, Fabienne Mackay, Charles R Mackay
Scientific Reports|August 6, 2020
IL-17F induces inflammation, dysfunction and cell death in mouse isletsTara Catterall, Stacey Fynch, Thomas W H Kay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 13, 2013
IL-21 promotes CD8+ CTL activity via the transcription factor T-betAndrew P R Sutherland, Nicole Joller, Monia Michaud, et al.
European Journal of Immunology|August 15, 2006
Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cellsCarrie A Fletcher, Andrew P R Sutherland, Joanna R Groom, et al.
Journal of Molecular Biology|October 11, 2005
Plasminogen activator inhibitor-2 is highly tolerant to P8 residue substitution--implications for serpin mechanistic model and prediction of nsSNP activitiesDaniel A Di Giusto, Andrew P R Sutherland, Lucy Jankova, et al.
European Journal of Immunology|June 23, 2006
BAFF costimulation of Toll-like receptor-activated B-1 cellsLai Guan Ng, Chee-Hoe Ng, Blanche Woehl, et al.
Plos One|December 11, 2019
Replacing murine insulin 1 with human insulin protects NOD mice from diabetesColleen M Elso, Nicholas A Scott, Lina Mariana, et al.
Molecular and Cellular Biology|March 11, 2009
Zinc finger protein Zbtb20 is essential for postnatal survival and glucose homeostasisAndrew P R Sutherland, Hai Zhang, Ye Zhang, et al.
Diabetes|February 12, 2009
Interleukin-21 is required for the development of type 1 diabetes in NOD miceAndrew P R Sutherland, Tom Van Belle, Andrea L Wurster, et al.
Scientific Reports|October 27, 2019
IL-21 regulates SOCS1 expression in autoreactive CD8<sup>+</sup> T cells but is not required for acquisition of CTL activity in the islets of non-obese diabetic miceAndrew P R Sutherland, Kate L Graham, Michelle Papadimitriou, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Pharmacology & Therapeutics|July 26, 2006
Targeting BAFF: immunomodulation for autoimmune diseases and lymphomasAndrew P R Sutherland, Fabienne Mackay, Charles R Mackay
Scientific Reports|August 6, 2020
IL-17F induces inflammation, dysfunction and cell death in mouse isletsTara Catterall, Stacey Fynch, Thomas W H Kay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 13, 2013
IL-21 promotes CD8+ CTL activity via the transcription factor T-betAndrew P R Sutherland, Nicole Joller, Monia Michaud, et al.
European Journal of Immunology|August 15, 2006
Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cellsCarrie A Fletcher, Andrew P R Sutherland, Joanna R Groom, et al.
Journal of Molecular Biology|October 11, 2005
Plasminogen activator inhibitor-2 is highly tolerant to P8 residue substitution--implications for serpin mechanistic model and prediction of nsSNP activitiesDaniel A Di Giusto, Andrew P R Sutherland, Lucy Jankova, et al.
European Journal of Immunology|June 23, 2006
BAFF costimulation of Toll-like receptor-activated B-1 cellsLai Guan Ng, Chee-Hoe Ng, Blanche Woehl, et al.
Plos One|December 11, 2019
Replacing murine insulin 1 with human insulin protects NOD mice from diabetesColleen M Elso, Nicholas A Scott, Lina Mariana, et al.
Molecular and Cellular Biology|March 11, 2009
Zinc finger protein Zbtb20 is essential for postnatal survival and glucose homeostasisAndrew P R Sutherland, Hai Zhang, Ye Zhang, et al.
Diabetes|February 12, 2009
Interleukin-21 is required for the development of type 1 diabetes in NOD miceAndrew P R Sutherland, Tom Van Belle, Andrea L Wurster, et al.
Scientific Reports|October 27, 2019
IL-21 regulates SOCS1 expression in autoreactive CD8<sup>+</sup> T cells but is not required for acquisition of CTL activity in the islets of non-obese diabetic miceAndrew P R Sutherland, Kate L Graham, Michelle Papadimitriou, et al.
Pageof 2